CYTOKINETICS INC — Director's Dealing 2021

Jun 2, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CYTOKINETICS INC (CYTK)
CIK: 0001061983
Period of Report: 2021-06-01

Reporting Person: Cragg David (Chief HR & Admin Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-06-01	Common Stock	M	6562	$6.3	Acquired	167733	Direct
2021-06-01	Common Stock	S	6562	$21.6274	Disposed	161171	Direct
2021-06-01	Common Stock	M	8437	$6.3	Acquired	169608	Direct
2021-06-01	Common Stock	S	8437	$21.6274	Disposed	161171	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-06-01	Incentive Stock Option (right to buy)	$6.3	M	8437	Disposed	2022-03-05	Common Stock (8437)	Direct
2021-06-01	Non-Qualified Stock Option (right to buy)	$6.3	M	6562	Disposed	2022-03-05	Common Stock (6562)	Direct

Footnotes

F1: Transaction effected pursuant to a 10b5-1 plan entered into by the Reporting Person on March 31, 2021.

F2: Includes up to 13,678 shares of common stock purchased pursuant to the Cytokinetics, Incorporated Employee Stock Purchase Plan.